Parallel Advisors, LLC Xencor Inc Transaction History

Parallel Advisors, LLC

  • $4.34 Billion
  • Q4 2024

A detailed history of Parallel Advisors, LLC transactions in Xencor Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 136 shares of XNCR stock, worth $2,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136
Previous 173 21.39%
Holding current value
$2,088
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
SELL
$19.43 - $26.84 $718 - $993
-37 Reduced 21.39%
136 $3,000
Q3 2024

Nov 13, 2024
SELL
$15.7 - $21.65 $18,447 - $25,438
-1,175 Reduced 87.17%
173 $3,000
Q2 2024

Aug 08, 2024
SELL
$18.21 - $24.5 $8,030 - $10,804
-441 Reduced 24.65%
1,348 $25,000
Q1 2024

May 06, 2024
BUY
$18.65 - $26.52 $8,206 - $11,668
440 Added 32.62%
1,789 $39,000
Q4 2023

Feb 09, 2024
BUY
$16.53 - $21.42 $16,777 - $21,741
1,015 Added 303.89%
1,349 $28,000
Q3 2023

May 20, 2024
BUY
$20.08 - $25.39 $6,365 - $8,048
317 Added 1864.71%
334 $6,000
Q3 2023

Nov 13, 2023
BUY
$20.08 - $25.39 $6,365 - $8,048
317 Added 1864.71%
334 $6,000
Q1 2023

May 20, 2024
SELL
$25.95 - $36.95 $45,983 - $65,475
-1,772 Reduced 99.05%
17 $0
Q1 2023

Apr 25, 2023
SELL
$25.95 - $36.95 $155 - $221
-6 Reduced 26.09%
17 $0
Q4 2022

Feb 03, 2023
BUY
$24.79 - $30.86 $24 - $30
1 Added 4.55%
23 $0
Q3 2022

Nov 10, 2022
BUY
$24.62 - $32.44 $123 - $162
5 Added 29.41%
22 $1,000
Q2 2022

Aug 01, 2022
SELL
$19.74 - $29.01 $335 - $493
-17 Reduced 50.0%
17 $0
Q1 2022

Apr 28, 2022
SELL
$26.68 - $41.63 $2,214 - $3,455
-83 Reduced 70.94%
34 $1,000
Q4 2021

Jan 20, 2022
BUY
$33.67 - $43.44 $1,851 - $2,389
55 Added 88.71%
117 $5,000
Q3 2021

Nov 02, 2021
SELL
$30.65 - $35.68 $6,160 - $7,171
-201 Reduced 76.43%
62 $2,000
Q2 2021

Aug 06, 2021
BUY
$34.33 - $44.68 $9,028 - $11,750
263 New
263 $9,000
Q2 2018

Jul 30, 2018
SELL
$28.41 - $42.41 $5,682 - $8,482
-200 Closed
0 $0
Q1 2018

May 08, 2018
BUY
$21.18 - $33.78 $4,236 - $6,756
200 New
200 $6,000

Others Institutions Holding XNCR

# of Institutions
199
Shares Held
73.7M
Call Options Held
1.7K
Put Options Held
4.2K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $917M
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email